Dechra Pharmaceuticals PLC — Director's Dealing 2013

Sep 3, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1554N

Dechra Pharmaceuticals PLC

03 September 2013

3 September 2013

Dechra® Pharmaceuticals PLC

("Dechra" or "the Company")

Director / PDMR shareholding

Dechra Pharmaceuticals PLC has been notified that on 3 September 2013 Julian Heslop, Non-Executive Director, purchased 5,000 ordinary shares in the Company at a price of £6.935 each.  

Following this acquisition, Julian Heslop's beneficial interest in the Company is 10,000 shares (0.01% of the current issued share capital).

For further information, please contact:

Zoe Goulding, Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals business.  Our expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSNKNDKABKDACK